Search Results - Offidani, Massimo

Refine Results
  1. 1
    Introduction to “Immunotherapies for Multiple Myeloma”

    Introduction to “Immunotherapies for Multiple Myeloma” by Offidani, Massimo, Petrucci, Maria Teresa

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Novel Experimental Drugs for Treatment of Multiple Myeloma

    Novel Experimental Drugs for Treatment of Multiple Myeloma by Offidani, Massimo, Corvatta, Laura, Morè, Sonia, Olivieri, Attilio

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety

    Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety by Offidani, Massimo, Corvatta, Laura, Morè, Sonia, Olivieri, Attilio

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    An evidence-based review of ixazomib citrate and its potential in the treatment of newly diagnosed multiple myeloma

    An evidence-based review of ixazomib citrate and its potential in the treatment of newly diagnosed multiple myeloma by Offidani, Massimo, Corvatta, Laura, Caraffa, Patrizia, Gentili, Silvia, Maracci, Laura, Leoni, Pietro

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma Treatment

    Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma Treatment by Morè, Sonia, Petrucci, Maria Teresa, Corvatta, Laura, Fazio, Francesca, Offidani, Massimo, Olivieri, Attilio

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments

    Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments by Offidani, Massimo, Corvatta, Laura, Morè, Sonia, Nappi, Davide, Martinelli, Giovanni, Olivieri, Attilio, Cerchione, Claudio

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration

    Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration by Nabissi, Massimo, Morelli, Maria Beatrice, Offidani, Massimo, Amantini, Consuelo, Gentili, Silvia, Soriani, Alessandra, Cardinali, Claudio, Leoni, Pietro, Santoni, Giorgio

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Autologous Stem Cell Transplantation in Multiple Myeloma: Where Are We and Where Do We Want to Go?

    Autologous Stem Cell Transplantation in Multiple Myeloma: Where Are We and Where Do We Want to Go? by Morè, Sonia, Corvatta, Laura, Manieri, Valentina Maria, Saraceni, Francesco, Scortechini, Ilaria, Mancini, Giorgia, Fiorentini, Alessandro, Olivieri, Attilio, Offidani, Massimo

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol

    A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: t... by Efficace, Fabio, Boccadoro, Mario, Palumbo, Antonio, Petrucci, Maria Teresa, Cottone, Francesco, Cannella, Laura, Zamagni, Elena, Niscola, Pasquale, Kyriakou, Charalampia, Caravita, Tommaso, Offidani, Massimo, Mandelli, Franco, Cavo, Michele

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Anticoagulation and Vessel Recanalization in Cirrhotic Patients with Splanchnic Vein Thrombosis: A Multidisciplinary “Real Life” Experience

    Anticoagulation and Vessel Recanalization in Cirrhotic Patients with Splanchnic Vein Thrombosis: A Multidisciplinary “Real Life” Experience by Rupoli, Serena, Fiorentini, Alessandro, Morsia, Erika, Svegliati-Baroni, Gianluca, Micucci, Giorgia, Maroni, Luca, Garvey, Kimberly Blaine, Fiorentini, Alessandro, Riva, Alessandra, Da Lio, Lidia, Benedetti, Antonio, Offidani, Massimo, Olivieri, Attilio, Giuseppe, Tarantino

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies

    Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies by Bringhen, Sara, Mina, Roberto, Petrucci, Maria Teresa, Gaidano, Gianluca, Ballanti, Stelvio, Musto, Pellegrino, Offidani, Massimo, Spada, Stefano, Benevolo, Giulia, Ponticelli, Elena, Galieni, Piero, Cavo, Michele, Di Toritto, Tommaso Caravita, Di Raimondo, Francesco, Montefusco, Vittorio, Palumbo, Antonio, Boccadoro, Mario, Larocca, Alessandra

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM

    Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM by Jakubowiak, Andrzej, Offidani, Massimo, Pégourie, Brigitte, De La Rubia, Javier, Garderet, Laurent, Laribi, Kamel, Bosi, Alberto, Marasca, Roberto, Laubach, Jacob, Mohrbacher, Ann, Carella, Angelo Michele, Singhal, Anil K., Tsao, L. Claire, Lynch, Mark, Bleickardt, Eric, Jou, Ying-Ming, Robbins, Michael, Palumbo, Antonio

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell’Adulto Multiple Myeloma Working Party study

    Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophospha... by Musto, Pellegrino, Simeon, Vittorio, Grossi, Alberto, Gay, Francesca, Bringhen, Sara, Larocca, Alessandra, Guariglia, Roberto, Pietrantuono, Giuseppe, Villani, Oreste, D’Arena, Giovanni, Cuomo, Carmela, Musto, Clelia, Morabito, Fortunato, Petrucci, Maria Teresa, Offidani, Massimo, Zamagni, Elena, Tacchetti, Paola, Conticello, Concetta, Milone, Giuseppe, Palumbo, Antonio, Cavo, Michele, Boccadoro, Mario

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs

    Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs by Montefusco, Vittorio, Gay, Francesca, Spada, Stefano, De Paoli, Lorenzo, Di Raimondo, Francesco, Ribolla, Rossella, Musolino, Caterina, Patriarca, Francesca, Musto, Pellegrino, Galieni, Piero, Ballanti, Stelvio, Nozzoli, Chiara, Cascavilla, Nicola, Ben-Yehuda, Dina, Nagler, Arnon, Hajek, Roman, Offidani, Massimo, Liberati, Anna Marina, Sonneveld, Pieter, Cavo, Michele, Corradini, Paolo, Boccadoro, Mario

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD)

    The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD) by Terragna, Carolina, Remondini, Daniel, Martello, Marina, Zamagni, Elena, Pantani, Lucia, Patriarca, Francesca, Pezzi, Annalisa, Levi, Giuseppe, Offidani, Massimo, Proserpio, Ilaria, De Sabbata, Giovanni, Tacchetti, Paola, Cangialosi, Clotilde, Ciambelli, Fabrizio, Viganò, Clara Virginia, Dico, Flores Angela, Santacroce, Barbara, Borsi, Enrica, Brioli, Annamaria, Marzocchi, Giulia, Castellani, Gastone, Martinelli, Giovanni, Palumbo, Antonio, Cavo, Michele

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study

    Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study by Cattaneo, Chiara, Busca, Alessandro, Gramegna, Doriana, Farina, Francesca, Candoni, Anna, Piedimonte, Monica, Fracchiolla, Nicola, Pagani, Chiara, Principe, Maria Ilaria Del, Tisi, Maria Chiara, Offidani, Massimo, Fanci, Rosa, Ballanti, Stelvio, Spolzino, Angelica, Criscuolo, Marianna, Marchesi, Francesco, Nadali, Gianpaolo, Delia, Mario, Picardi, Marco, Sciumé, Margherita, Mancini, Valentina, Olivieri, Attilio, Tumbarello, Mario, Rossi, Giuseppe, Pagano, Livio

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents

    Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents by Mina, Roberto, Joseph, Nisha S., Gay, Francesca, Kastritis, Efstathios, Petrucci, Maria Teresa, Kaufman, Jonathan L., Montefusco, Vittorio, Gavriatopoulou, Maria, Patriarca, Francesca, Omedé, Paola, Boise, Lawrence H., Roussou, Maria, Giuliani, Nicola, Oliva, Stefania, Offidani, Massimo, Belotti, Angelo, Jaye, David L., De Paoli, Lorenzo, Terpos, Evangelos, Lonial, Sagar, Boccadoro, Mario, Nooka, Ajay K., Dimopoulos, Meletios A.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score

    Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score by D’Agostino, Mattia, Larocca, Alessandra, Offidani, Massimo, Liberati, Anna Marina, Gaidano, Gianluca, Petrucci, Maria Teresa, Derudas, Daniele, Capra, Andrea, Zambello, Renato, Cascavilla, Nicola, de Fabritiis, Paolo, Innao, Vanessa, Bonello, Francesca, Patriarca, Francesca, Benevolo, Giulia, Giuliani, Nicola, Aitoro, Gabriele, Guglielmelli, Tommasina, Di Raimondo, Francesco, Corradini, Paolo, Musto, Pellegrino, Hájek, Roman, Sonneveld, Pieter, Boccadoro, Mario, Bringhen, Sara

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials

    First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled... by Larocca, Alessandra, Mina, Roberto, Offidani, Massimo, Liberati, Anna Marina, Ledda, Antonio, Patriarca, Francesca, Evangelista, Andrea, Spada, Stefano, Benevolo, Giulia, Oddolo, Daniela, Innao, Vanessa, Cangiolosi, Clotilde, Bernardini, Annalisa, Musto, Pellegrino, Amico, Valeria, Fraticelli, Vincenzo, Paris, Laura, Giuliani, Nicola, Falcone, Antonietta Pia, Zambello, Renato, De Paoli, Lorenzo, Romano, Alessandra, Palumbo, Antonio, Montefusco, Vittorio, Hájek, Roman, Boccadoro, Mario, Bringhen, Sara

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study

    Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase... by Mina, Roberto, Belotti, Angelo, Petrucci, Maria Teresa, Zambello, Renato, Capra, Andrea, Di Lullo, Giacomo, Ronconi, Sonia, Pescosta, Norbert, Grasso, Mariella, Monaco, Federico, Cellini, Claudia, Gobbi, Marco, Ballanti, Stelvio, de Fabritiis, Paolo, Mosca-Siez, Maria Letizia, Marchetti, Monia, Liberati, Anna Marina, Offidani, Massimo, Giuliani, Nicola, Ria, Roberto, Musto, Pellegrino, Romano, Alessandra, Sonneveld, Pieter, Boccadoro, Mario, Larocca, Alessandra

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: